- Accueil >
- Publications >
- High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial
High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial
Auteurs
Céline Callens, Marc Debled, Marc Delord, Isabelle Turbiez-Stalain, Corinne Veyret, Ivan Bièche, Etienne Brain